Teva

News

Novartis continues to build the case for its Aimovig migraine injection,with data showing it works in a tough-to-treat patient group.

News

Regulator cites issues with manufacturing plant

News

Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.

UK & Europe

Hikma has a new chief executive after Said Darwazah, the son of the company’s late founder, Samih Darwazah, stepped aside.

News

Aimovig notches up another late-stage trial success

News

Two AstraZeneca (AZ) drugs have been approved in Japan – its cancer drug Lynparza and its respiratory drug Fasenra.